Welcome to our dedicated page for BC BUD news (Ticker: BCBCF), a resource for investors and traders seeking the latest updates and insights on BC BUD stock.
The BC Bud Corporation (BCBCF) is a Canadian cannabis company known for its high-quality brands. Based in British Columbia, the company recently partnered with TobaRolling and BC Cannabis Stores, expanding its product distribution and availability. It has closed an initial tranche of a non-brokered private placement and secured loans through subsidiary BC Bud Holdings Corp. The company is poised for growth in North America and beyond, exploring M&A opportunities, focusing on direct delivery initiatives, and anticipating a prosperous future in the cannabis industry.
The BC Bud (BCBC) has announced an increase in its non-brokered private placement from $1 million to $1.5 million due to high demand. The company has completed the second tranche of the placement, raising $511,275 through the sale of 6,816,998 units at $0.075 per unit. Each unit includes one common share and one purchase warrant, allowing holders to acquire an additional share at $0.15 within 24 months.
The company previously closed the first tranche on January 17, 2025, raising $631,300. Total proceeds to date amount to $1.142 million through 15,234,330 units. The proceeds will support business development and working capital. Additionally, BCBC has granted 8 million stock options to directors, officers, and consultants, exercisable at $0.12 per share for two years.
The BC Bud (CSE: BCBC) (OTC: BCBCF) has announced the appointment of Ken Osborne to its Board of Directors, effective January 22, 2025. Osborne, a CFA Charterholder based in Vancouver, brings extensive experience in mergers and acquisitions, capital markets, and strategic advisory. As General Partner at Osborne Partners , he has led various successful transactions including acquisitions, equity financings, and venture debt mandates. Previously, he managed 11 acquisitions in telecom and agriculture technology sectors at TELUS
Concurrent with this appointment, Justin Chorbajian has resigned from the Board. CEO Brayden Sutton expressed confidence that Osborne's expertise will bring significant value as the company continues to scale and evolve.
The BC Bud (BCBCF) has successfully closed the initial tranche of its non-brokered private placement, raising $631,300 through the sale of 8,417,332 units at $0.075 per unit. Each unit includes one common share and one share purchase warrant, with warrants exercisable at $0.15 per share for 24 months.
No finder's fees were paid, and all securities are subject to a hold period until May 18, 2025. The proceeds will support business development and working capital. Additionally, the company has engaged Hillside Consulting & Media for a two-month marketing services agreement at $25,000 CAD monthly for various digital marketing and content creation services.
The BC Bud (BCBCF) has announced multiple strategic initiatives. The company is launching a non-brokered private placement aiming to raise up to $1,000,000 through the sale of 13,333,333 units at $0.075 per unit. Each unit includes one common share and one warrant, with warrants exercisable at $0.15 per share for 24 months.
The company has also begun accumulating XRP cryptocurrency through a Coinsquare account using its cash reserves. Additionally, BCBCF has engaged Red Cloud Securities Inc. for market-making services starting January 15th, 2025, at a monthly fee of $5,000. The agreement aims to maintain reasonable bid-offer spreads and improve share liquidity on the Canadian Securities Exchange.
The BC Bud (CSE: BCBC) (OTC: BCBCF) has announced the appointment of Alyssa Barry to its Board of Directors, effective December 31, 2024. Barry, the President of Alliance Advisors Investor Relations, brings 20 years of capital markets and investor relations experience. She co-founded irlabs in 2021, which was acquired by Alliance Advisors in 2024. Her track record includes raising over $1 billion in capital and serving as Corporate Secretary of Artis REIT. Barry was recently named one of Canada's Most Powerful Women: Top 100 and recognized in Business in Vancouver's Top 40 Under 40.
The announcement coincides with Brian Taylor's resignation from the Board of Directors, effective December 30, 2024.
The BC Bud has announced a strategic investment of CAD $250,000 in Ripple (XRP) cryptocurrency through Coinsquare, a regulated trading platform. The purchase will be executed throughout December 2024 and early 2025. The company views this investment as a way to protect and grow capital amid challenging financial conditions, citing XRP's increased legal legitimacy and potential market growth due to possible spot ETF approvals and favorable crypto policies. The investment will be made using cash reserves from Canadian accounts, with the company maintaining flexibility to adjust its XRP holdings based on market conditions.
The BC Bud Co (CSE: BCBC, OTCQB: BCBCF), a high-quality cannabis brand from British Columbia, Canada, has added Cary Alexander to its advisory board. Cary, a finance graduate from the University of Texas, has a background in acting, executive production, and significant experience in the cannabis industry. He has contributed to brands like Jeeter, Bloom, Packwoods, and Tyson 2.0, demonstrating expertise in financing, developing, and expanding cannabis brands. With the evolving cannabis landscape and increased legalization in places like Germany, Spain, and parts of the US, BC Bud Co aims to leverage Cary's insights and network to expand its portfolio and pursue opportunities in international markets. The company, however, has not yet initiated operations in the US nor identified acquisition targets. Despite DEA's efforts to reclassify cannabis, it remains federally prohibited.
The BC Bud (CSE: BCBC) (OTCQB: BCBCF) has appointed Sean Flynn as its Chief Commercial Officer. Mr. Flynn brings over 30 years of C-Suite experience in multi-national companies, with expertise in mergers & acquisitions, growth strategies, and operational excellence. His appointment aims to drive growth strategies and enhance commercial operations at The BC Bud Co.
The BC Bud (CSE: BCBC) (OTCQB: BCBCF) applauds DEA action to reschedule cannabis, preparing for North American opportunities. The US Department of Justice may reclassify cannabis as a Schedule III controlled substance, aligning it with prescription medications. The company is exploring M&A opportunities, focusing on direct delivery initiatives, and anticipating a prosperous 2024 in the cannabis market.
FAQ
What is the current stock price of BC BUD (BCBCF)?
What is the market cap of BC BUD (BCBCF)?
Where is The BC Bud Corporation based?
What recent partnerships has The BC Bud Corporation announced?
What financial transactions has The BC Bud Corporation recently closed?
What growth strategies is The BC Bud Corporation focusing on?
What is The BC Bud Corporation anticipating for the future?
